I couldn't taste anything; I freaked out because I couldn't find anything online; Interchange of vaccine products; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (I couldn't taste anything), ANXIETY (I freaked out because I couldn't find anything online) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069F21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Previously administered products included for Product used for unknown indication: JANSSEN Vaccine on 02-Apr-2021. Past adverse reactions to the above products included No adverse event with JANSSEN Vaccine. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA ALLERGY) for an unknown indication.    On 29-Nov-2021 at 12:30 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced AGEUSIA (I couldn't taste anything), ANXIETY (I freaked out because I couldn't find anything online) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). On 30-Nov-2021, AGEUSIA (I couldn't taste anything) had resolved. At the time of the report, ANXIETY (I freaked out because I couldn't find anything online) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown.            No treatment information was provided.  Company Comment-This is a spontaneous case concerning a 50-year-old, female patient with medical history of Interchange of vaccine products, since she received another brand of COVID-19 vaccine (COVID-19 vaccine Janssen) as previous dose who experienced the unexpected, non-serious, AESI event of Ageusia and she referred to get a negative test, although it is not detailed if it was a covid-19 test or other test. The patient received a mRNA-1273 vaccine for her booster shot on 29-NOV-2021. The event Ageusia occurred six hours after the booster dose of mRNA-1273 vaccine administration. The rechallenge is not applicable as patient received another brand of COVID-19 vaccine (COVID-19 vaccine Janssen) as previous dose and the events occurred after the booster dose and no other dose is expected at this moment. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 50-year-old, female patient with medical history of Interchange of vaccine products, since she received another brand of COVID-19 vaccine (COVID-19 vaccine Janssen) as previous dose who experienced the unexpected, non-serious, AESI event of Ageusia and she referred to get a negative test, although it is not detailed if it was a covid-19 test or other test. The patient received a mRNA-1273 vaccine for her booster shot on 29-NOV-2021. The event Ageusia occurred six hours after the booster dose of mRNA-1273 vaccine administration. The rechallenge is not applicable as patient received another brand of COVID-19 vaccine (COVID-19 vaccine Janssen) as previous dose and the events occurred after the booster dose and no other dose is expected at this moment. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.